MYC and breast cancer: Similarly, XBP1 expression appeared to be maintained by high transcriptional activity, which promotes triple‐negative breast cancer (Chen et al, 2014) and is a candidate therapeutic target in high Myc‐expressing breast cancer (Zhao et al, 2018).